Carbohydrate of the factor VIII/von Willebrand factor in von Willebrand's disease
- PMID: 315413
- PMCID: PMC371276
- DOI: 10.1172/JCI109585
Carbohydrate of the factor VIII/von Willebrand factor in von Willebrand's disease
Abstract
We have examined the plasma Factor VIII/von Willebrand factor (FVIII/vWF) molecule from 16 patients with von Willebrand's disease, and have found no evidence of a significant decrease of carbohydrate content in 15 of these patients. FVIII/vWF was isolated by preparative counter immunoelectrophoresis directly from plasma using antibody to Factor VIII-related antigen, reduced in sodium dodecyl sulfate in the presence of urea, and electrophoresed in 5% polyacrylamide gels to separate the FVIII/vWF subunit from other proteins. Duplicate gels were stained by either the periodic acid-Schiff (PAS) reaction or by Coomassie Brilliant Blue G250. The ratio of Coomassie: PAS was determined by spectrophotometric scanning of the gels. Transferrin was used as an internal reference standard. The ratio for 23 normal individuals was 2.4+/-0.38 and the observed range was 1.8-3.8. 15 patients with von Willebrand's disease fell within this range. One patient independently reported as having decreased FVIII/vWF carbohydrate was also studied by this technique. A ratio of 6.8 was found, indicative of decreased, though not absent, carbohydrate. Cold insoluble globulin did not represent a significant contaminant in these analyses. 11 of the von Willebrand's disease patients with normal FVIII/vWF carbohydrate had abnormal crossed immunoelectrophoretic patterns characterized by absence of the less anodic forms of Factor VIII-related antigen. Four patients had normal patterns. These studies indicate that an absence or decrease of PAS reactive FVIII/vWF carbohydrate is not a consistent abnormality in von Willebrand's disease.
Similar articles
-
Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease.J Lab Clin Med. 1983 Mar;101(3):411-25. J Lab Clin Med. 1983. PMID: 6186757
-
Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease.N Engl J Med. 1980 May 8;302(19):1047-51. doi: 10.1056/NEJM198005083021902. N Engl J Med. 1980. PMID: 6767976
-
Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease.J Clin Invest. 1977 Aug;60(2):390-404. doi: 10.1172/JCI108788. J Clin Invest. 1977. PMID: 17621 Free PMC article.
-
Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease.Semin Thromb Hemost. 2006 Sep;32(6):626-35. doi: 10.1055/s-2006-949668. Semin Thromb Hemost. 2006. PMID: 16977573 Review.
-
Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease.Blood Coagul Fibrinolysis. 2009 Mar;20(2):89-100. doi: 10.1097/MBC.0b013e3283254570. Blood Coagul Fibrinolysis. 2009. PMID: 19786936 Review.
Cited by
-
Properties of human asialo-factor VIII. A ristocetin-independent platelet-aggregating agent.J Clin Invest. 1981 Aug;68(2):321-8. doi: 10.1172/jci110259. J Clin Invest. 1981. PMID: 6790574 Free PMC article.
-
Carbohydrate moiety of von Willebrand factor is not necessary for maintaining multimeric structure and ristocetin cofactor activity but protects from proteolytic degradation.J Clin Invest. 1984 Dec;74(6):2049-55. doi: 10.1172/JCI111628. J Clin Invest. 1984. PMID: 6239876 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous